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Abstract 
Enterotoxigenic Escherichia coli (ETEC) is one of the main causes of childhood diarrhea 
and in travelers in developing countries. ETEC expresses one or both of two different 
enterotoxin subtypes: heat-stable toxins (Sn, heat-labile toxin (L T) and more than 25 
different colonization factors (CFs) that mediate adherence to the intestinal cell wall. A 
total number of 3459 stool specimens were tested from patients enrolled in the 2% 
routine surveillance system in lCDDR, B during the period of March, 2009 to July, 2010 
and 10% (n=364) ETEC strains were detected at the Immunology Laboratory. Genotypic, 
multiplex-PCR and phenotypic, GM I-enzyme-linked immunosorbent assay (GM 1-
ELISA) method were chosen to compare those isolated strains. lmmuno Dot blot assay 
using specific monoclonal antibodies (MAbs) was done for the detection of colonization 
factors (CFs). Thirty strains have shown discrepancy in results among 364 ETEC strains. 
In which, 17% (n=5) was positive for heat stable toxin (Sn, 10% (n=3) was positive for 
the heat labile toxin (L n, and 73% (n=22) was positive for both L T and ST toxin in case 
ofPCR method but in ELISA, L T was found 17%, ST was 33% and LT/ST was 37%. 
About 67% of ETEC strains from stool specimens were colonization factor (CF) positive. 
Of these, 40% ofLT toxin, 70% ofST toxin and 55% ofLT/ST toxin producing ETEC 
strains were CF positive. Among different colonization factors CS5 + CS6 and CS 14 
were the predominant phenotypes, followed by CS6, CFAlI , CS 17, CS I+CS3+CS21, 
CS2+CS3+CS21 in terms of occurrence whereas, CS2 + CS3 expressing ETEC strains 
were less frequently isolated from stool specimens. We did not find a very good 
similarity in results derived from genotypic and phenotypic methods. About 13% of PCR 
positive strains were negative by ELISA among those 30 strains. In PCR, ST was 17% 
whereas 33% found in ELISA and L T was 10% by PCR whereas 17% found in ELISA. 
In conclusion, we therefore did not find similar rates of L T and ST by the PCR method; it 
might due to low concentration of DNA in template that was prepared. It is possible that 
either the eilB or eslA gene is present as a silent gene or, alternatively, that the levels of 
expression of the gene for these toxin are so low that the toxin was not detected by the 
ELISA method. Thus in future study, rRT-PCR can be carried out to evaluate genotypic 
and phenotypic toxin results specificity. 
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Introduction 
1.1 Introduction 
In developing countries, each year roughly four billion episodes of acute diarrhea or 
approximately 3.2 episodes per child occur among children under five years of age [5). The 
major etiologic agents that account for the estimated 1.5 million deaths per year are 
enterotoxigenic Escherichia coli (ETEC), rotavirus, Vibrio cholerae, and Shigella spp. [2, I) ; all 
are known to be endemic in essentially all developing countries. Diarrhea (from the Greek word) 
means "flowing through" [3) . It is the condition of having three or more loose or liquid bowel 
movements per day [4). The loss of fluids through diarrhea can cause dehydration and electrolyte 
imbalances. 
During diarrhea the body loses water and electrolytes (both of which are necessary for life) in the 
form of liquid stool and vomitus. If the water and salts are not replaced fast, the body gets 
dehydrated. If more than 10"10 of the body's fluid is lost death may occur. Children are more 
likely than adults to die from diarrhea because they become dehydrated more quickly. In 
Bangladesh waterborne diseases are common and some diseases have a characteristic seasonal 
pattern, increasing exponentially at certain predicted periods of the year but remaining endemic 
all year round [6) . 
I .2 Causes of diarrhea: 
A few of the more common causes of diarrhea include the following: 
• Bacterial iDfections. Several types of bacteria consumed through contaminated food or 
water can cause diarrhea. Common organisms include: Vibrio cholerae, enterotoxigenic 
Escherichia coli (ETEC), Campylobacter, Salmonella, Shigella spp. 
• Viral infections. Many viruses cause diarrhea, including rotavirus, adenovirus,Norwalk 
virus, cytomegalovirus, herpes simplex virus, and viral hepatitis. 
• Parasites. Parasites can enter the body through food or water and settle in the digestive 
system. Parasites that cause diarrhea include Giardia lamblia, Entamoeba histolytica, and 
Cryptosporidium. 
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• Food intolerances. Some people are unable to digest food components such as artificial 
sweeteners and lactose---the sugar found in milk. 
• Reaction to medicines. Antibiotics, blood pressure medications, cancer drugs, and 
antacids containing magnesium can all cause diarrhea. 
People who visit foreign countries are at risk for traveler' s diarrhea, which is caused by eating 
food or drinking water contaminated with bacteria, viruses, or parasites. Traveler's diarrhea can 
be a problem for people visiting developing countries. In travelers however bacterial infections 
predominate [6]. 
1.3 Different types of diarrhea: 
Q Secretory diarrhea 
o Osmotic diarrhea 
o Exudative diarrhea 
o Motility-related diarrhea 
o Inflammatory diarrhea 
o Dysentery 
1.3.1 Secretory diarrhea: 
In secretory diarrhea there is an increase in the active secretion, or an inhibition of absorption. 
There is little to no structural damage of lumen, intestinal brush boarder. Therefore, to maintain a 
charge balance in the lumen, sodium is carried with it, along with water. In this type of diarrhea 
intestinal fluid secretion is isotonic with plasma even during fasting [7] . 
1.3.2 Osmotic diarrhea: 
Osmotic diarrhea occurs when too much water is drawn into the bowels. This can be the result of 
mal digestion (e.g., pancreatic disease or celiac disease), in which the nutrients are left in the 
lumen to pull in water. Osmotic diarrhea can also be caused by osmotic laxatives (which work to 
alleviate constipation by drawing water into the bowels). In healthy individuals, too much 
magnesium or vitamin C or undigested lactose can produce osmotic diarrhea and distention of 
the bowel [7] . 
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1.3.3 Exudative diarrhea: 
Exudative diarrhea occurs with the presence of blood and pus in the stool. This occurs with 
inflammatory bowel diseases, such as Crohn's disease or ulcerative colitis, and other severe 
infections such as E. coli or other forms of food poisoning [7] . 
1.3.4 Motility-related diarrhea: 
Motility-related diarrhea occurs when the motility of the gastrointestinal tract (GI) is abnormal. 
This type of diarrhea may arise if the ingested food moves too quickly in the gastrointestinal tract 
and there is not enough contact time between the food and the intestinal membrane, which results 
in an insufficient absorbance of both the nutrients and water [7] . 
1.3.5 Inflammatory diarrhea: 
Inflammatory diarrhea occurs when there is damage to the mucosal lining or brush border, which 
leads to a passive loss of protein-rich fluids, and a decreased ability to absorb these lost fluids . It 
can be caused by bacterial infections, viral infections, parasitic infections, or autoimmune 
problems such as inflammatory bowel diseases [7] . 
1.3.6 Dysentery : 
Generally, if there is blood visible in the stools, it is not diarrhea, but dysentery. The blood is 
trace of an invasion of bowel tissue. Dysentery is a symptom of, among others, Shigella, 
enteroinvasive E. coli. and En/amoeba his/oiytica [7]. 
1.4 Transmission and symptoms of diarrhea: 
Diarrheal diseases are transmitted through the fecal-oral route and are spread through 
contaminated food and drinking water or from person to person as a result of poor hygiene and 
sanitation. Infants who are not exclusively breast fed, young children, and adults who are 
malnourished or have weakened immune systems are at greatest risk [4] . Diarrhea may be 
accompanied by loose motion, cramping, abdominal pain, bloating, and nausea. Depending on 
the cause, a person may have a fever or bloody stools [8] . 
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1.5 General features of E.coli : 
Theodor Escherich first described E. coli in 1885, as Bacterium coli commune, which he isolated 
from the feces of newborns. It was later renamed Escherichia coli, and for many years the 
bacterium was simply considered to be a commensal organism of the large intestine. It was not 
until 1935 that a strain of E. coli was shown to be the cause of an outbreak of diarrhea among 
infants [14]. 
Figure 1.1: E. coli on the surface of human small intestine 
Source: Visuals UnlimitediCorbis 
The GI tract of most warm-blooded animals is colonized by E. coli within hours or a few days 
after birth. The bacterium is ingested in foods or water or obtained directly from other 
individuals handling the infant. The human bowel is usually colonized within 40 hours of birth 
[15]. E. coli can adhere to the mucus overlying the large intestine. Once established, an E. coli 
strain may persist for months or years. Resident strains shift over a long period (weeks to 
months), and more rapidly after enteric infection or antimicrobial chemotherapy that perturbs the 
normal flora [16, 17]. The basis for these shifts and the ecology of Escherichia coli in the 
intestine of humans are poorly understood despite the vast amount of information on almost 
every other aspect of the organism's existence. The entire DNA base sequence of the E. coli 
genome has been known since 1997 [18]. 
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Figure 1.2: An Escherichia coli cell is imaged using tapping mode AFM under dry condition. 
Well preserved pili and flagella structures can be seen clearly. The size of the cell is about 1.9um 
long and I um wide. The width of pili is about 20nm and flagellum is about 30nm. 
(Source:hnp://www.icmm.csic.eslspmage/spmageview) 
E. coli is the head of the large bacterial family, Enterobacteriaceae, the enteric bacteria, which 
are facultatively anaerobic Gram-negative rods that live in the intestinal tracts of animals in 
health and disease. A number of genera within the family are human intestinal pathogens (e.g. 
Salmonella, Shigella, Yersinia). Several others are normal colonists of the human gastrointestinal 
tract (e.g. Escherichia, Enterobacter, Klebsiella), but these bacteria, as well, may occasionally be 
associated with diseases of humans [18]. 
The genome of E. coli consists of a single circular chromosome of about 4 to 5 million base pairs 
(bp), depending on the strain, and may include multiple plasm ids of various sizes (4 kb to several 
hundred kb) that are dispersed within the cytoplasm. The DNA of several strains has been 
sequenced and the differences between these have helped explain some aspects of virulence and 
pathogenicity [19]. 
1.6 Pathogenesis of E. coli: 
Nowadays, particularly for diarrheagenic strains (those that cause diarrhea) pathogenic E. coli 
are classified based on their unique virulence factors and can only be identified by these traits. 
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Hence, analysis for pathogenic E. coli usually requires that the isolates first be identified as E. 
coli before testing for virulence markers. Pathogenic strains of E. coli are responsible for three 
types of infections in humans: urinary tract infections (UTI), neonatal meningitis, and intestinal 
diseases (gastroenteritis) [22]. Different pathotypes and different virulence determinants account 
for pathogenesis of infection caused by E coli [20]. 
A) The seven recognized pathotypes for diarrheagenic E coli are as follows: 
I . Enterotoxigenic E. coli (ETEC) 
2. Enteropathogenic E. coli (EPEC) 
3. Enteroaggregative E. coli (EAEC) 
4. Enterohemorrhagic E. coli (EHEC, also known as Shiga toxin-producing E. coli [STEC] 
5. Enteroinvasive E. coli (EIEC) 
6. Diffusely adherent E. coli (DAEC) 
7. Cytolethal distending toxin producing E. coli (CDT-EC) 
B) Extra-intestinal E. coli (ExPEC) 
I. Neonatal meningitis E. coli (NMEC) 
2. Uropathogenic E. coli (UPEC) 
3. Avian pathogenic E. coli (APEC) 
Over 700 antigenic types (serotypes) of E. coli are recognized based on 0 , H, and K antigens. At 
one time serotyping was important in distinguishing the small number of strains that actually 
cause disease. Thus, the serotype 0157:H7 (0 refers to somatic antigen; H refers to flagellar 
antigen) is uniquely responsible for causing HUS (hemolytic uremic syndrome) [18-21]. 
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Figure 1.3: E. coli with 0 and H serotype 
Source: http://mgl .scripps.edulpeople/goodseIUillustration/public 
Some pathogenic E coli strains produce cytotoxic enterotoxins (encoded on plasmid or 
bacteriophage DNA) that induce watery diarrhea without causing substantial tissue damage. 
Other strains harbor plasmid-encoded invasion factors that allow invasion of the mucosa or 
plasmid or bacteriophage-encoded cytotoxic enterotoxins that can cause tissue damage [2 I, 23] . 
Diarrbeagenic E. coli: virulence determinants and characteristics of disease are as follows: 
1. EIEe (Enteroinvasive E. coli) 
-Nonfimbrial adhesins, possibly outer membrane protein 
-Invasive (penetrate and multiply within epithelial cells) 
-Does not produce shiga toxin 
-Dysentery-like diarrhea (mucous, blood), severe inflammation, fever 
-Causes a syndrome with profuse diarrhea and high fever. 
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2. EPEC (Enteropathogenic E. coli) 
-Non fimbrial adhesin (intimin) 
-EPEC adherence factor (EAF) enables localized adherence of bacteria to intestinal cells 
-Moderately invasive (not as invasive as Shigella or EIEC) 
-Does not produce L T or ST; some reports of shiga-like toxin 
-Usually infantile diarrhea; watery diarrhea with blood, some inflammation, no fever; symptoms 
-Probably result mainly from invasion rather than toxigenesis 
3. EAEC (Enteroaggregative E. coli) 
-Adhesins not characterized 
-Non invasive 
-Have fimbriae which aggregate tissue culture cells 
-Produce ST-like EAST (EnteroAggregative ST) toxin and a hemolysin 
-Persistent diarrhea in young children without inflammation or fever 
-The significance of EAEC strains in human disease is controversial 
4. EHEC (Enterohemorrhagic E. coli) 
-Adhesins not characterized, probably fimbriae 
-Moderately invasive 
-Bind tightly to cells 
-Does not produce L Tor ST but does produce shiga toxin 
-Pediatric diarrhea, copious bloody discharge (hemorrhagic colitis), intense inflammatory 
response, may be complicated by hemolytic uremia 
-Characterized by the production ofverotoxin or Shiga toxins (Six) 
-Although Slxl and Slx2 are most often implicated in human illness, several variants of Slx2 exist 
5. DAEC (Diffusely adherent E. coli) 
-Produce a fimbrial adhesin or a related adhesin [18]. 
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-Patients infected with DAEC had watery diarrhea without blood or fecal leukocytes 
induce a cytopathic signal transduction effect. 
6. CDT -EC (Cytolethal distending toxin producing E. coil) 
-Latest class of diarrheagenic E. coli. 
-COT-producing E. coli additionally possessed the virulence factors ofEPEC or EAEC. 
-Some species of campylobacter also produce a cytolethal-distending toxin related to that of eDT-
producing E. coli and which also causes distension and eventual disintegration of cells of certain lines 
[24). 
7. ETEC (Enterotoxigenic E. coli) 
-Can produce two proteinaceous enterotoxins: L T and/or ST toxin 
-Fimbrial adhesins e.g. eFA I, CFArI, K88. K99 to bind enterocyte cells in the small intestine 
-Non invasive 
-Watery diarrhea in infants and travelers; no inflammation, no fever 
-They do not leave the intestinal lumen 
-Virulence genes carried on plasm ids; ST genes on transposon 
In Table 1.1 there is a short comparison of the pathogenic mechanisms of diarrheagenic E. coli 
Table 1.1: Comparison oftbe patbogenic mecbanisms ofdiarrbeagenic E. coli 
E. coli class Main virnlence factor 
EIEC (Enteroinvasive E. coli) Plasmid-mediate invasion genes 
EPEC (Enteropathogenic E.coll) Bundle-forming pili, intimin, Tir 
EAEC (Enteroaggregative E. coli) Enteroaggregative heat-stable enterotoxin (EAST!) 
EHEC (Enterohemorrhagic E.coll) Verocytotoxin / Shiga-like toxin 
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DAEC (Diffusedly adherent E. coli) Hemolysin and cytotoxic necrotising factor I (CNF I) 
CDT-EC (Cytolethal distending Cytolethal distending toxin (COn 
toxin (CDT)- producing E. coli) 
ETEC (Enterotoxigenic E. coli) Heat-stable (ST) and heat-labile (L T) enterotoxins and 
colonization factors (CFs). 
1.7 Historical aspects of E. coli. infection: 
The history of enterotoxigenic E. coli begins in 1956 in Calcutta [10]. De and his colleagues 
injected live strains of E. coli, isolated from children and adults with a cholera-like illness, into 
isolated ileal loops of rabbits and found that large amounts of fluid accumulated in the loops, 
similar to that seen with Vibrio cholerae. However, they did not test the filtrates of these cultures 
to determine whether they produced an enterotoxin. These findings were not followed up until 
1968, when Sack reported studies, also in Calcutta, of adults and children with a cholera-like 
illness, who had almost pure growth of E. coli in both stool and the small intestine [II]. These E. 
coli isolates were found to produce a strong cholera-like secretory response in rabbit ileal loops, 
both as live cultures and as culture filtrates [12]. The patients were also found to have antitoxin 
responses to the heat-labile enterotoxin produced by these organisms [13]. 
1.8 Enterotoxigenic E. coli (ETEC) in diarrheal disease: 
ETEC is defined as the E. coli that contains at least one member of two defined groups of 
enterotoxins: ST and L T [25]. It is the most common among the seven diarrheagenic E. coli 
strains and is an important human and animal pathogen [26]. ETEC infection occurs when a 
person eats foods or drinks water contaminated with ETEC. Specific virulence factors 
differentiate ETEC from other categories of diarrheagenic E. coli such as enterotoxins and 
colonization factors (CFs) [25, 27]. ETEC belongs to a heterogeneous family oflactose 
fermenting E. coli, belonging to a wide variety of 0 (somatic), K (capsular) and H (flagellar) 
antigenic types, which produce enterotoxins [27]. Characteristically, ETEC colonize the small 
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intestine by adhering to the epithelium and induce secretion by elaborating toxins without 
invasion of or damage to cells [26]. 
1.9 Epidemiology ofETEC infection: 
Infants and children up to 5 years of age are more susceptible to ETEC diarrhea [28-30]. This 
susceptibility of young children has been observed due to poor public health and hygiene 
conditions as well lack of immunity and prior exposure [28, 29]. The incidence increases again in 
those over IS years of age [30, 31]. Studies from India and Bangladesh first described ETEC to 
be a cause of adult diarrhea resembling cholera in the severity of infection [31, 32]. Studies in 
Bangladesh showed that the incidence of mixed infections increase with age [33] . In cases of 
mixed infections in children, rotavirus is the most common, followed by other bacterial 
enteropathogens, e.g., v: cholerae, Shigella spp. [34-36] . In traveler's diarrhea, 
enteroaggregative E. coli and Campylobacter spp. have been common pathogens together with 
ETEC [37, 38]. The incidence of ETEC infections in developing countries decreases after 5 years 
of age with a decrease of infections between the ages of 5 to IS years [31]. 
1.10 Clinical features of ETEC diarrhea patients: 
Diarrheal disease caused by ETEC was first recognized as a cholera-like illness in both adults 
and children [39]. The diarrhea produced by ETEC is of the secretory type: the disease begins 
with a sudden onset of watery stool (without blood or inflammatory cells) and often vomiting, 
which lead to dehydration from the loss of fluids and electrolytes (sodium, potassium, chloride, 
and bicarbonate) in the stool [39, 40]. The loss of fluids progressively results in a dry mouth, 
rapid pulse, lethargy, decreased skin turgor; decreased blood pressure, muscle cramps, and 
eventually shock in the most severe forms [40]. 
1.11 ETEC virulence factors: 
Pathogenesis of ETEC strains is mediated by two major virulence factors, enterotoxins and 
colonization factor antigen (CFA). The ability of ETEC to adhere to the intestinal epithelium of 
the host is an important virulence determinant, and adhesion is mediated by pertinacious surface 
appendages called colonization factors (41) are designated by colonization factor antigen (CFA), 
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CS (coli surface antigen), or putative colonization factor (PFA). ETEC produces many defined 
colonization factors(pili/fimbrial or nonfimbrial), under plasmid control [42,43]. After 
colonization, ETEC produces one or two enterotoxins called heat labile toxin (L T) and heat 
stable toxin (ST) and strains may express either or both [10). 
1.12 Toxins: 
There are two types of toxins secreted by ETEC to cause diarrhea. The toxins are heat labile 
toxin (LT) and heat stable toxin (ST). They are further classified according to their property and 
the host they colonize. 
ETEClIoxln 
I ST· I (Sf .. ) I ST·I I 
7 \ 
'--1 ST-p--'-, STh----', 'Ilb , 
" LT-I/II ~ 
I 
Ir-L T~P-I L,;-l'h----.II L T·II a' LT ~I b 
Figure 1.4: Classification of ETEC enterotoxins 
1.12. 1 Heat-stable toxin (ST): 
Characteristics of ST toxin are as follow: 
Heat stable enterotoxin is a small, monomeric, single-peptide toxin that includes two unrelated 
classes: STa and STb, which differ in both structure and mechanism of action. STs are so named 
because they are stable at 100° C for 15 min. Only toxins of the STa class have been associated 
with human disease. The STb toxin is associated with animal disease [44-47) . 
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Figure 1.5: Molecular structure of ST 
(Source: OPM database) 
Structural features: 
Low-molecular-mass polypeptides that contain mUltiple cysteine residues forming disulfide 
bonds that is essential for their heat stability and biologic activity [45]. STa toxin is a - 2-kDa 
peptide containing 18 or 19 amino acid residues [47]. 
STb toxin is a 48-amino-acid peptide containing two disulphide bonds. There are two variants of 
STa, designated STp (ST porcine or STla) and STh (ST human or STlb) after their 
initial discovery in strains isolated from pigs or humans, respectively. Both variants can be found 
in human ETEC strains [27]. 
Functions: 
STa: activates guanylate cyclase resulting in ion secretion [45] and STh: increase intracellular calcium 
resulting in ion secretion [46]. 
Mechanism: 
STa binds to extracellular ligand-binding domain of guanylate cyclase C (GC-C) in the brush-
border membrane of intestine epithelial cells, resulting in activation the guanylate cyclase 
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activity of this receptor, leading to increased intracellular cGMP levels. Na+ and cr absorption is 
inhibited in villus tip cells, whereas secretion ofCr is stimulated in intestinal crypt cells. The 
pathway involved may include cGMP-dependent kinase and cAMP-dependent kinase [47] . The 
intestinal receptor for STb has not been identified. STb leads to the release of serotonin, 
production of prostaglandin E2, and increased free cytosolic Ca2+ concentration [46, 47]. 
1.12.2 Heat-labile toxin (L T): 
Characteristics of L T toxin are as follow: 
Two antigenically distinct types : LT-I and LT-Il. LT-J is plasmid-encoded [50]. LT-I is 
expressed by E. coli strains that are pathogenic for both humans and animals [44]. LT-U only 
produced by strains isolated from animals [50]. The LT-ll serogroup of the LT family shows 
55 to 57% identity to L T -I and CTX in the A subunit but essentially no homology to L T-I or 
CTX in the B subunits [49-51] . 
Figure 1.6: Architecture of the cholera toxin (CT) AB5 heterohexamer which is very closely 
related to the heat labile enterotoxin (L T) from enterotoxigenic E. coli . 
(Source: http://skuld.bmsc.washington.edulraster3d1exampleslexamples.html) 
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Structural features: 
Structurally and functionally similar to cholera enterotox.in. L T -I is an oligomeric toxin of 
86 KDa composed of one A subunit (28-KDa) and five identical B subunits (11.5-KDa) [48]. 
The B subunits are arranged in a ring or "doughnut" form [51.52]. The B subunit binds 
ganglioside GMI in the host cell membrane. The A subunit is proteolytically nicked to form the 
AI and A2 subunits that remain associated by virtue of a disulfide bond. The AI peptide functions 
enzymatically as an ADP-ribosyltransferase [50]. 
L T - f1 is associated primarily with animal-specific ETEC strains, subgrouped into two antigenic 
variatants: L T-lla and LT-f1b. The A subunit ofL T-IJ acts in the same manner as that of L T-1. B 
subunit of L T-lla binds ganglioside GD II" while L T -lIb binds GDI8 [52-54]. 
Functions: 
ADP ribosylates and activates adenylate cyclase resulting in ion secretion 
Mechanism: 
L T transfers the ADP-ribose from NAD to arginine residue 20 I on the alpha subunit of GTP" 
blocking their GTPase activity, so adenylate cyclase permanently activated, leading to increased 
intracellular concentrations of cAMP. cAMP activates the cAMP-dependent protein kinase A 
(PKA). This activation leads to phosphorylation of ion channels in the apical membrane of 
intestine epithelial cells. A principal target is CFTR (cystic fibrosis transmembrane conductance 
regulator). Thus there is increased secretion of cr from intestinal crypt cells and decreased 
absorption ofNa + and cr by villus tip cells [53, 54]. 
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1.12.3 Mechanism of pathogenesis: 
ETEC strains cause diarrhea through the action of the enterotoxins L T and ST. These strains may 
express an LT only, an ST only, or both an L T and an ST. 
-> After binding to the host cell membranes, the L T toxin is endocytosed and translocated 
through the cell in a process involvingtrans-Golgi vesicular transport [54). 
-> The cellular target of L T is adenyl ate cyclase located on the basolateral membrane of 
epithelial cells. 
-> The AI peptide of LT toxin acts by transferring an ADP-ribosyl moiety from NAD to the 
alpha subunit of the GTP-binding protein, Gs, which stimulatesadenylate cyclase activity. ADP-
ribosylation of the Gso< subunit results in adenylate cyclase being permanently activated, 
leading to increased levels of intracellular cyclic AMP (cAMP). 
-> cAMP-dependent protein kinase (A kinase) is thereby activated, resulting in secretion of 
anions (predominantly CI- by a direct effect, and HC03 - indirectly) by crypt cells and a 
decrease in absorption ofNa + and CI- by absorptive cells [55). 
-> ST is thought to act by binding the ST membrane receptor, GC-C. Activation of GC-C results 
in increased levels of intracellular cGMP. 
-> cGMP exerts its effects in increasing chloride secretion and decreasing NaCI absorption [56, 
57). The increased luminal ion content draws water passively, resulting in a net water loss into 
the gut lumen. 
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Figure 1.7: Classic mechanisms of action of ETEC toxins 
1.13 Colonization factors (CFs): 
To cause diarrhea, ETEC strains must adhere to small bowel enterocytes, an event mediated by 
colonization factors (CFs). The colonization factors are mainly funbrial or fibrillar proteins, 
although some colonization factors are not fimbrial in structure [58]. More than 22 colonization 
factors (CFs) have been recognized among human ETEC and many more are about to be 
characterized [43]. Three major morphologic varieties ofCFs exist: 
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• rigid rods, 
• bundle-forming flexible rods, and 
• thin flexible wiry structures. 
For example, the prototype CF All, has rigid rod-shaped fimbria. It is a single fimbrilar structure 
[59]. A nomenclature for the CFs designating them as coli surface antigen (CS) was introduced 
in the mid-1990s [43]. Some of the better-characterized CFs can be subdivided into different 
families, i.e., the colonization factor I-like group (including CF All, CS I, CS2, CS4, CS 14, and 
CSI7) [43], and the coli surface 5-like group (with CS5, CS7, CSI8, and CS20) [60], and those 
that are unique (CS3, CS6, and CS I 0 to CS 12). 
CF AID is composed of three distinct coli surface antigens CS I, CS2, and CS3 respectively. The 
fimbrillar stucture CS3 could be expressed alone or together with either the fimbrial CS I or CS2. 
CFAlIU is a bundle forming pilus with homology to the type 4 fimbrial family. Similarly, 
CF AlIV was shown to consist of the non- fimbrial CS6 alone or in combination with either CS4 
or CS5 fimbriae [61]. Some more characterized CFs was called putative colonization factors 
(PCFs) combined with the serogroups of the strains from which the fimbriae were first identified. 
Putative CFs are found with varying frequencies such as CSI4 (pCFOI66) and CSI2 
(PCFO 159). Newly described CF named Longus has been found on some human ETEC stains 
[62]. 
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Table 1.2: Past and present designations for colonization factors of ETEC 
Nomenclature Type of antigen 
Old New 
CFAlI CFAlI F 
CSI CS I F 
CS2 CS2 F 
CS3 CS3 f 
CS4 CS4 F 
CS5 CS5 H 
CS6 CS6 nF 
CS7 CS7 H 
CFAlIIl CS8 F 
2230 CSIO nF 
PCFOl48 CSII f 
PCFO l59 CSI2 F 
PCF09 CSI3 f 
PCFOl66 CS I4 F 
8786 CSI5 nF 
CSI7 CSI7 F 
PCF020 CSI8 F 
CSI9 CSI9 F 
CS20 CS20 F 
Longus CS21 F 
CS22 CS22 f 
Abbreviations: CS, Coli Surface antigen; CFA, Colonization Factor Antigen; PCFO, putative 
colonization factor; F, fimbrial ; f, fibrillae; nF, nonfimbrial; H, helical. All except CF All have 
the CS designation [42]. 
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Correlation between presence of colonization factors and toxin of ETEC is also important, which 
is presented in Table 1.3. 
Table 1.3: Combination of CFs and toxin of ETEC 
CS Morpbology Molecular Enterotoxins 
weigbt(Kd) 
CFNI F 15 ST+LT 
CSI F 16.8 ST+LT 
CS2 F 15.3 ST+LT 
CS3 f 15.1 ST+LT 
CS4 F 17 ST+LT 
CS5 H 21 ST+LT 
CS6 nF 14.5/ 16.0 ST+LT 
CS7 H 21.5 ST+LT 
CS8 F 18 LT 
CSIO nF 16 ST 
CSI2 F 19 ST+LT 
CSI4 F 15.5/17.0 ST+LT 
CSI7 F 15.5/ 17.5 LT 
Abbreviations: CS- Coli Surface antigen, CFA- Colonization Factor Antigen, F- fimbrial , f-
fibrillae, nF- non- fimbrial, H- helical , KO- kilo Dalton, L T- heat labile toxin, ST- heat stable 
toxin. 
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There are cross-reactive epitopes that have been considered as candidates for vaccine 
development within each of these families (63). Of the wide range ofCFs, the most commonly 
present on diarrhoeagenic strains and those seen on 50 to 80% of isolates include CF NI , CS I, 
CS2, CS3, CS4, CS5, CS6, CS7, CSI4, CSI7 and CS21 (42). Other ETEC fImbriae, known as 
longus serogroups has also been found on a large proportion of human ETEC [64, 65). However, 
CFs has not been detected on all ETEC and roughly on 40-50"10 of all strains worldwide not 
known colonization factors have been detected. This may be probably due to absence of adhesins 
or because of lack of specific antibodies or molecular methods for their detection (10). 
Figure 1.8: CF expressing ETEC. E. coli produce a variety of colonization factors , many of 
which are hair-like structures of various morphologies called fImbriae (also called pili) or 
fIbrillae. a) Long, straight colonization factor antigen (CFA)IIII fImbriae ofETEC (5- 7 nm in 
diameter) protruding peritrichously from the bacterial surface. b) Abundant long, straight CF NI 
fImbriae (5- 7 nm) ofETEC contrasting with thicker, wavy flagella . c) Thin (2- 3 nm), flexible, 
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wiry CS3 fibrillar structures produced by ETEC that extend several micrometres from the cell 
surface. 
Source: Nature Reviews Microbiology volume: 2, 123-140 (February 2004). 
1.14 Seasonality ofETEC: 
In Bangladesh, ETEC follows a very characteristic biannual seasonality with two separate peaks, 
one at the beginning of the hot season, that is, the spring, and another peak in the autumn 
months, just after the monsoons, but it remains endemic all year [38, 66, 62). Such as seasonality 
may be initiated by climate and spread by environmental factors. Seasonality for the different 
toxin phenotypes has also been suggested, with ST -producing ETEC strains being more common 
in the summer (30, 67) whereas L T -producing ETEC strains are present all year round and do 
not show any seasonality. 
1.15 ETEC infection and malnutrition: 
As for other diarrheal diseases, preexisting malnutrition can lead to more severe enteric 
infections, including those caused by ETEC, possibly due to the immunocompromised nature of 
the host that also predisposes these individuals to a greater bacterial load on the mucosal surfaces 
of the gut than the well-nourished child (68). Micronutrient deficiency such as vitamin A and 
zinc is quite common in developing countries and generally increases the morbidity due to 
diarrheal illnesses [69, 70). 
1.16 Protection through breast feeding: 
Breast feeding is known to reduce overall diarrhea and mortality [71 , 72]. Since secretory 
immunoglobulin A antibodies to CFs and enterotoxin are present in breast milk samples from 
mothers in developing countries [73, 74, 75] , it would be natural to assume that breastfed infants 
should be protected from ETEC diarrhea. This effect is short term and does not last long after 
infancy, and an overall protection is not seen in the crucial first 2 to 3 years of life [30, 67, 76). 
The limited capacity of breast milk to protect against ETEC diarrhea in developing countries can 
also be attributed to other social and behavioral factors. 
221 Pagc 
Introduction 
1.17 Treatment and management: 
The treatment for ETEC diarrhoea includes rehydration strategies and antimicrobial therapy. The 
correction and maintenance of hydration is always most important. Antimicrobials are useful 
only when the diagnosis or suspicion of ETEC-related diarrhea is made. 
1.17.1 Rehydration: 
Intravenous fluids (such as Ringer' s lactate) are required initially for all patients with severe 
dehydration. Supplement of fluid and minerals in the form of oral saline (ORS) is the easiest way 
of rehydration until the diarrhea ceases. 
1.17.2 Antimicrobials: 
Diarrhea in children is caused not only by ETEC but also by other bacterial and viral agents. The 
antimicrobial treatment of traveler's diarrhea has changed over the years because of increasing 
antimicrobial resistance [77]. When ETEC were first recognized, the bacteria were usually 
highly sensitive to tetracyclines and trimethoprim-sulfamethoxazole [78]. However, with time, 
antibiotic resistance emerged; antimicrobials that have been used for the treatment include 
doxycycline, trimethoprim-sulfamethoxazole, erythromycin, norfloxacin, ciprofloxacin, 
ofloxacin, azithromycin, and rifamycin [77, 78]. 
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1.18 Aim of the study: 
Acute diarrheal diseases are a major health problem in developing countries and ETEC is the 
major bacterial pathogen contributing to the disease burden in children less than 5 years of age. 
The objective of the study was to determine the prevalence of enterotoxigenic Escherichia coli 
(ETEC) infection among 2% systemic surveillance study of the ICDDR, B. and analyzed the data 
for understanding the phenotypic and genotypic difference of the pathogen. 
The specific objectives of the present study were: 
• Determination and confirmation of enterotoxigenic E. coli in surveillance patients by 
stool culture method. 
• Rapid detection of ETEC toxin (L T, ST or both) by molecular technique (PCR). 
• Characterization of ETEC by immunochemical methods for phenotypic determination by 
ELISA. 
• To determine the presence and distribution of colonization factors in these strains. 
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2.1 Methods and materials 
This study is carried out at International Centre for Diarrheal Disease Research, 
Bangladesh (ICDDR, B) in Dhaka. Stool samples were collected from diarrheal patients 
enrolled in the 2% routine surveillance at the Laboratory Science Division (LSD), 
ICDDR, B. In the surveillance system every 50th patient attending the hospital is 
screened for ETEC. This study is approved by the Research Review Committee (RRC) 
and Ethical Review Committee (ERC) of the centre. 
2.2 Samples collection and screening: 
Stool or rectal swab samples were collected in sterile plastic containers from every 50th 
patient attending the hospital. These specimens were then screened for ETEC, PCR and 
ganglioside GMI-ELISA techniques were performed to confirm genotypic and 
phenotypic detection of ETEC toxin. Later, ETEC toxin positive colonies were tesed by 
dot-blot method to detect the colonization factors. The overview of the study plan to 
detect Enterotoxigenic Escherichia coli (ETEC) is shown in the following flow chart 
(2.1): 
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2.3: Over view of this study plan: 
Diarrheal patients enrolled in 2% routine surveillance 
Stool and rectal swab from every 50th patient 
I 
C For ETEC detection ~ --~---~ 
GMI-ELISA to 
detect toxin 
phenotype 
Streaked on 
MacConkey plate 
E. coli specific colony 
was tested for ETEC 
PCR to detect L T 
and or ST 
genotype 
If PCR positive 
ImmunoDot 
blot to 
detect CFs 
Figure 2.1: Flowchart for detection ofETEC 
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2.4: Identification ofETEC: 
E. coli was recovered easily from clinical specimens on MacConkey agar, on the basis of 
their morphology. To confirm detection ofETEC freshly collected stool samples were 
plated on to MacConkey agar plates and incubated at 37°C overnight. Six individual 
lactose-fermenting colonies with deep pink colour from each clinical sample were tested. 
MacConkey agar plates with E.coli colonies store at 4-8°C for ~ I week The enterotoxins 
were detected by PCR method and ganglioside GM I-ELISA method. 
Figure 2.2: E. coli colonies growing on MacConkey agar plate 
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2.4.1: Detection ofLT and/or ST by Polymerize Chain Reaction: 
• Template Preparation: 
100 ilL of PBS was poured to each Eppendorf tube. 
,j.. 
One loop of bacteria was taken in each tube (from a pool of six colonies). 
,j.. 
Heated at 100 °c on water bath for 10 minutes. 
,j.. 
Transferred the tubes on ice and kept for a minute. 
,j.. 
Centrifuged the tubes at 12,000 rpm for 10 minutes. 
,j.. 
The supernatant was the template, ready to use. 
• Specific primer sequence used: 
Toxins Primers Primer Sequence 
LT Forward 5' - ACGGCGTTACTATCCTCTC - 3' 
Reverse 5' - TGGTCTCGGTCAGAT ATGTG - 3' 
8Th Forward 5' - AGTGGTCCTGAAAGCATG- 3' 
Reverse 5' - TACAAGCAGGATTACAACAC - 3' 
8Tp Forward 5' - TCTTTCCCCTCTTTT - 3' 
Reverse 5' - ACAGGCAGGA TT ACAAAG - 3' 
• Master mixture preparation: 
Table 2.1: Preparatiou of master mixture 
No Reagent Amount per 1 sample 
reaction 
I PCR buffer (with MgCh) 5.0 III 
2 dNTP mix 8.0 ilL 
3 Primer L T mixture 4.0 III 
4 Primer STp mixture 4.0 III 
5 Primer STh mixture 4.0 III 
6 MgG2 1.0 III 
7 Taq polymerase 0.3 III 
8 Distilled water 21.7 III 
Total 48.0 III 
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.:. 2)IL DNA templates added in each tube. 
• Thennal cycle: 
First step 
Second step 
Third step 
94°C for 5 minutes (initial denaturation) 
94°C for denaturation-30 seconds 
54°C for prime annealing-30 seconds 
n oc for elongation -30 seconds 
n oc for 5 minutes (final extension step) 
4 °C until used. 
• Agarose Gel Preparation (2%): 
40 cycles 
• Ultra pure agarose of2 g was mixed in 100 ml IX TBE buffer (Invitogen, 
ultra pure). 
• Heated in micro oven for four minutes and poured on specific gel- tray. 
• 4JlL ethidium bromide added in the gel. 
• Comb fixed and allowed 30-40 minute for gel fonnation. 
• Gel Electrophoresis: 
• Stained with loading dye. (4 )IL dye with 25 ILL PCR product) 
• Electophrosis run for 30 minutes at 150V 
• Gel photographed under UV light. 
2.4.2: Detection ofLT and/or ST toxin producing isolation by ELISA: 
The procedure for detection of LT is based on the binding of the B-subunit of the toxin to 
GM I ganglioside and the detection of ST is based on its ability to inhibit the binding of 
ST to the GMI and ST-CTB conjugates by ELISA technique. 
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o Procedure 
• For coating purpose 100 ItL of ganglioside GM I solution, 0.5 ItglmL, was 
added to each well of an ELISA plate and incubated at room temperature 
overnight (these plates could be stored at +4°C for about 2 weeks until 
used). 
• GM I-coated plates were washed twice with PBS and then a concentrated 
solution of non-interacting protein; bovine serum albumin (BSA) (0.1 % 
BSA-PBS, 200 ItL /well) is added to all plate wells and incubated at 37°C 
for 30 minutes. This step is known as blocking, because the serum proteins 
block non-specific adsorption of other proteins to the plate. 
• Plates were washed once with PBS and 100 ItL of Luria-Bertani (LB) 
broth containing 45 IlglmL of lincomycin was added to each well of the 
plate. 
• Six individual colonies (for one sample) from MacConkey plates (using 
which PCR was done) were inoculated, single bacterial colony/well, with 
wooden sticks. The outside rows and columns of the ELISA plate were 
excluded to avoid background. 
• The plates were covered with a plastic film (to prevent evaporation) and 
incubated with shaking at 250 rpm overnight at 37"C. These plates were 
used for the detection of L T toxin. 
• Another GM I coated ELISA plate (for each to be tested for L T) was 
washed twice with PBS and blocked with 200 ItL 0.1% BSA-PBS at 37°C 
for 30 minutes. These plates were used for the detection of ST. 
• The plates were washed once with PBS and then 100 ItL of recombinant 
ST-CTB conjugate solution was added. Plates were incubated at room 
temperature for 60 min. 
• The plates were washed three times with PBS and then 50 ilL volumes of 
the overnight cultures from the plates for detection of L T were transferred 
to the corresponding wells in the plates used for the detection of ST. Then 
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50 j.lL of anti-ST MAb ST (1:3 dilution) was immediately added and 
incubated at room temperature for 90 min. 
• Following this the plates for the detection of L T were washed three times 
with PBS contained 0.05% Tween and 100 j.lL of anti-L T MAb L T 
39: 13: 1 was added immediately and incubated at room temperature for 90 
mm. 
• Both types of plates (L T and ST) were washed three times with PBS-
Tween. 
• After that 100 j.lL of conjugate (anti-mouse IgG-HRP, I: 1000 dilution in 
BSA-PBS-Tween) was added into each well and incubated at room 
temperature for 90 minutes. 
• All plates were washed three times with PBS-Tween. 
• The substrate solution (prepared immediately before use) was added at 
100 j.lL Iwell and incubated at room temperature. Optical density was 
measured at 450 nm after incubation for about 20 minutes (maximal 
absorbance should not exceed 1.5) in a Titertek microplate reader. 
• For each plate LT-positive, ST-positive, LT and ST positive, LTand ST 
negative strains were used as control to interpret the result and control the 
experiment. 
2.4.3: Interpretation of results: 
~ For detection of L T: The background was defmed as the mean 
absorbance determined for LT -negative control strains. A positive result 
was an absorbance at 450 nm value of ~ mean background value was used 
as the cut off level for positive samples. 
~ For detection ofST: The background was defined as the mean of the 
absorbance at 450 nm of the ST -negative control strains. The 50% 
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inhibition concentration value (IC50) was calculated according to the 
equation below: 
lC50 = mean absorbance for ST - negative control strains (E. coli E34420C and 286Cz) 
2 
.:. The results were calculated as ~50"10 inhibition of the absorbance value 
measured as compared to the absorbance value obtained with the negative 
reference strains . 
• :. LT positive result: Absorbance value of ~O. 1 above background . 
• :. An isolate was considered enterotoxin positive if~ 1 colony showed a 
positive reaction in ST - and/or L T ELISA . 
• :- The test was invalid if the reference strain gave a result that was not 
consistent with its assigned toxin profile. 
2.5: Phenotypic detection of Colonization factors (CFs): 
The presence ofCFs on the ETEC isolates was detected by rapid dot blot assay using 
specific monoclonal antibodies for the different antigens. Toxin positive colonies on 
MacConkey agar plate were plated on to colonization factor antigen agar (CFA agar) 
with bile salts and plates were incubated at 37°C, overnight. For testing for CS21 only, 
colonies were cultured on Trypticase Soy agar (TSA) plate containing 5% sheep blood. 
From each sample, enterotoxin positive E. coli colonies from CFA plus bile, and TSA 
plates are tested for the expression of CF All, CS I, CS2, CS3, CS4, CS5, CS6, CS7, CS8, 
CS 12, CS 14, CS 17 and CS21 by a dot blot assay using monoclonal antibodies specific 
for the different CS antigens. 
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o Procedure: 
• Nitrocellulose membrane sheets or strips were cut, approx. 5x5mmldot, one sheet 
or strip for each CF-type to test. Before blocking the nitrocellulose membranes 
gloves and forceps were used. 
• Strips of nitrocellulose filter paper (0.45 11m, Sigma, St. Louis, MO) were soaked 
in phosphate buffered saline (PBS, 10 mM, pH 7.2) and allowed to dry for 5-30 
minutes. 
• Two ilL of bacterial suspension (corresponding to 4-10 McFarland standards) was 
applied on the strips as a dot on the membrane using a micropipette and allowed 
to dry for at least five minutes (the membranes could be stored refrigerated at 4-
8°C for about I week). 
• The membrane was blocked in 1% BSA-PBS for 20 minutes at room temperature 
(l8-25°C) on a platform rotator (He idol ph Rotamax 120) with slow rocking 
(approximately at 3 x g). An incubation tray (BioRad) was used for nitrocellulose 
strips. 
• After the blocking liquid was discarded, the same volume of antibody solution 
monoclonal antibodies diluted 1 :30-1 :50 was added and incubated for two hours 
in a humid chamber at room temperature on the rotary shaker. Antibody solution 
was prepared in 0. 1% BSA-PBS with 0.05% Tween 20. 
• After washing 3 times with PBS-0.05 % Tween20 the same volume of the enzyme 
conjugate diluted in 0.1 % BSA-PBS-0.05 % Tween (goat anti-mouse IgG HRP 
Jackson, dilution I : 15(0) was added and incubated for two hours in a humid 
chamber at room temperature on the rotator. 
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• Strips were washed 3x5 minutes with PBS-O.05% Tween and once with PBS and 
substrate solution (4-chloro-l-naphtol-H202 in TBS) was added to develop color 
for about fifteen minutes. 
• The membranes were thoroughly washed with tap water and dried. 
2.5.1: Interpretation of results: 
Black, bluish or gray dots on the strips represented positive reactions. The color intensity 
was compared with positive controls on each strip. For the test to be valid the control 
strains all gave positive results for assigned CFs. 
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3.1: Results 
From March, 2009 to July, 2010, 3459 stool specimens were tested for Enterotoxigenic 
Escherichia coli (ETEC). About 10 % (n=364) ofETEC was seen among the patients 
enrolled in 2% surveillance study, in the Immunology Laboratory at lCDDR, B. 
3.2 : Characterization of study subjects: 
3.2.1 Toxin profiles ofETEC strains: 
Enterotoxigenic E. coli isolates from the stool samples of the patients with acute diarrhea 
were tested for toxin production. Heat labile enterotoxin (L T) and heat stable enterotoxin 
(ST) gene specific primers were used to identify the toxin genes using the PCR method 
(Figure: 3. 1). 
LT--
STh STp 
Figure 3.1: Agarose gel electrophoresis for the detection ofL T 1ST genes of Escherichia 
coli isolated from diarrheal stool specimens. Lane A and 1- DNA ladder, lane B-D are for 
control strains and lane E represent negative control for LT/ST. Lane F-H and J-M are 
study samples. All strains are positive except strains of lane K and M. Lane F-H and lane 
J of strains represent L T toxin and lane L of strain represents LT ISTp toxin 
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PCR results confirmed ETEC positive strains. Strains were found to express L T was 10% 
and 17% strains expressed ST whereas 73% ETEC strains expressed L T and ST 
simultaneously. 
Genotypically Toxin Determination 
80% 73% 
<n 
~70% 
0-60% oST a 
c<S 50% 
<n I LT 
........ 40% 
0 
-- 30% oLT/ST c 1?Ok 
c1.) 20% 10% u 
:L; 10% 
Cl-. 0% 
ST LT LT/ST 
Enterotoxins 
Figure 3.2: Distribution of enterotoxins in ETEC isolated from the stool samples are 
detected by Genotypic method (PCR). 
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More specifically, in case of ST toxin, STh was detected as 60% and STp represents 40% 
of the ST toxin. Additionally, in case ofL T/ST toxin, 91 % strains were positive for 
L T/STh while only 9% was positive for L T/STp. 
Percent of Two Varients ofST Toxin 
STp, 40% 
STh, 60% 
R ~ 
Figure.3.3: Two variants of ST toxin. 
Percent of Two Varients of LT/ST Toxin 
o IT/STh 
OlT/STp 
IT/STh, 91% 
Figure.3.4: Two variants of L T/ST toxin. 
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3.2.2: Toxin phenotype: 
After detection of the toxins genotypically, the positive colonies were subjected to 
ELISA for the phenotypic detection. Of the 30 ETEC strains collected from stool 
specimens; 33% (n = I 0) were only ST producers, 17% (n=5) were only L T producers 
and 37% (n = II) were L T and ST producers. In all the age groups, the ST only-
producing isolates were the most prevalent, followed by L T - and ST -producing ETEC 
isolates and LT only-producing ETEC isolates (Fig. 3.5). 
Percent of Phenotypic ETEC Toxins 
40% 37% 
... 33% 
.!! 35% 
D-
E 30% 
'" ... 25% . ST 
-o 20% 17% . LT 
.. 
g) 15% oLT/ST 
.l!l 
c 10% 
.. 
5% ... .. 
.. 0% D.. 
ST LT LT/ST 
Enterotoxins 
Figure 3.5: Distribution of Phenotypic enterotoxins (by ELISA) in ETEC isolated from 
the stool samples. 
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3.3: Immuno Dot blot assay for CFA characterization: 
Phenotypic characterization of colonization factors of the 30 ETEC isolates were also 
carried out by immuno dot-blot assay applying 13 different colonization factors specific 
monoclonal antibodies. (Figure: 3.6) 
14 
11 
Figure 3.6: Colonization factors detected on ETEC using immuno dot blot assay. The 
spots number I and 2 represent positive control for each specific colonization factor 
against specific CFs. Spots 8, II and 14 are positive strains for (CS I +CS3+CS21), CS7 
and CSI4 respectively. Rest of the strains was negative for all \3 colonization factors. 
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3.3.1: Percentage of CF positive and CF negative strains in case of different 
toxins: 
Among the 30 toxin positive ETEC isolates 67% (n= 20) ETEC strains were found to be 
colonization factor (CF) positive for I or more of the 13 CFs and remaining 33% (n= 10) 
strains were considered as CF negative as they did not show any positive spot on the 
nitrocellulose strips. 
ETEC-ST strains showed a higher frequency of detectable CFs then ETEC-L T strains. 
For L T toxin, 40% (2 of 5) strains were CF positive; 70% (7 of 10) strains were CF 
positive for ST toxin and 55% (6 of II) strains were CF positive for LT/ST toxin. The 
following figures show percentage of CF positive and negative strains in case of different 
toxins. 
80% 
70% 
,......., 70% 
~ 60% 
'-' 
rJl 50% Q) 
~ 
- 40% CF+% 0 
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.- 30% U 
~ 20% cCF-% ~ 
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0% 
ST LT LT/ST 
Toxin type 
Figure 3.7: Distribution of colonization factors in different ETEC isolates 
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3.3.2: OveraH percentage of different Colonization factors: 
Again, overall percentage of 13 detected CFs are shown in the figure (Fig3.8). The coli 
surface (CS) antigen CS5+CS6 and CS 14 (pCFO 166) of the colonization factor antigen 
(CFA) were most prevalent, followed by CS5+CS6 and PCFO 166 were 20%. 
Additionally, other detected CF decreased to 15% which were CS6. However CFAII, 
CS I +CS3+CS21 , CS2+CS3+CS and CS 17 were 10% and CS+CS3 were 5% 
020% 
. CS2+CS3 
. CFAII 
Percentage ofCFs in ETEC Strains 
010% . 5% 
,', .. ~ 
~ ...;; -
" . 
, ' , 010% 
oCS5+CS6 OCS17 
o CS14 (PCF0166) • CS1+CS3+CS21 0 CS2+CS3+CS21 
Figure 3.8: Percentage of CFs in ETEC isolates. 
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For different ETEC toxin type specific colonization factor expression has been observed. 
CS5+CS6, CSI7, CSI4(PCFOI66), CS2+CS3+CS21 (Longus) were expressed in ST,LT 
and LT/ST; CS6 were expressed in LT and LT/ST; CSI+CS3+CS21 (Longus), 
CS2+CS3 were expressed only in ST and CF All was expressed in L T/ST. Distribution of 
CFs among different toxin expressing ETEC is summarized in figure: 3.9. 
A comparison of the toxin pattern and the expression of different CFs was carried out 
which is shown in Table 3.1 
Table 3.1 Association of toxins and CFs in ETEC isolates 
Toxin produced Total no. ofETEC CF types (s) No. ( % of) isolates 
isolates produced 
ST 12 CSI7 I (8 ) 
CS2+CS3 I (8 ) 
CS5+CS6 2 ( 17 ) 
CS6 3 (25) 
CSI4(PCFOI66) 2 ( 17) 
CS I +CS3+CS2 1 2 ( 17) 
CS2+CS3+CS21 I (8 ) 
LT 6 CS5+CS6 I ( 17 ) 
CSI7 I ( 17 ) 
CS 14(PCFO 166) 3 (50) 
CS2+CS3+CS21 I ( 17) 
LT/ST 9 CS5+CS6 2 (22) 
CFAlI I( II) 
CSI7 I ( II ) 
CS6 I ( I I ) 
CS2+CS3+CS21 2 (22) 
CS 14(pCFO 166) 2 (22) 
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Figure 3.9: Distribution of Colonization factors among different toxin expressing ETEC 
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3.4: Comparism of Genotypic (PCR) and Phenotypic (ELISA) method: 
PCR showed that 17% of all strains were ETEC-ST, 10% were ETEC-L T and 73% were 
ETEC-LT/ST. However, only 37% were positive for both toxin types by GMI-ELISA. 
73% 
37% 
33% 
17% 17% 
10% 
I 
ST LT LT/ST 
I CJ peR CJ ELISA I 
Figure 3.10: Percentage ETEC toxin between PCR and GMI-ELISA. 
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4.1 Discussion 
Enterotoxigenic Escherichia coli (ETEC) is an important pathogen that causes diarrheal 
diseases. Of the seven recognized diarrheagenic categories of Escherichia coli [27], 
ETEC is the most common, particularly in the developing world [80] . There are a variety 
of different genotypic and phenotypic methods available for detection of ETEC toxins 
and colonization factors in clinical isolates. We compared multiplex PCR and GMI-
ELISA to evaluate whether these methods gave similar results or not. 
A total number of 3459 stool specimens were tested from patients enrolled in the 2% 
routine surveillance system in ICDDR, B during the period of March, 2009 to July, 2010 
and \0% (n=364) ETEC strains were detected at the Immunology Laboratory. From those 
30 discrepant ETEC strains were again analyzed to determine genotypic and phenotypic 
differences. PCR showed high levels of sensitivity and specificity and took less time to 
perform. There were three groups of enterotoxins isolated in the ETEC positive isolates. 
Among 30 discrepant strains L T was detected in 10%, ST was 17% and L T 1ST was 73% 
by PCR. In case of ELISA, L T was in 17%, ST in 33% and L T/ST in 37% of strains thus 
almost 90% of the ETEC strains expressed L T, either L T alone or in combination with 
ST. Rest 13% were not detected by ELISA method. 
It was observed that 40% of the L T only-producing ETEC isolates, 70% of the ST only-
and 55% of the LT- and ST-producing ETEC isolates expressed CFs. 
In the present study different types of colonization factors were also observed. Within the 
30 discrepant ETEC isolates, CS5 + CS6 and CS 14 were the predominant phenotypes, 
followed by CS6, CFAII, CSI7, CSI+CS3+CS21, CS2+CS3+CS21 whereas, CS2+CS3 
expressing ETEC strains were less frequently isolated from stool specimens. 
Among the strains, the most prevalent colonization factor CS 14 was found in LT, ST and 
L T/ST toxin expressing ETEC strains. The antigen, CF All was detected in ST positive 
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ETEC strains. In combination with other colonization factors CS21 was present on all 
types of toxin producing ETEC. CS 1 +CS3+CS21 and CS2+CS3 were found in ST toxin 
producing ETEC. 
For this purpose, two laboratory techniques PCR and ELISA were used. The isolates that 
were positive for PCR were analyzed by ELISA test to see whether the PCR results for 
toxins matches with the results of the ELISA test. PCR is a genotypic procedure in which 
gene for specific toxins are amplified using toxin specific primers and the results are seen 
in a gel under UV light on the other hand ELISA is a toxin phenotype detection 
procedure in which color intensity accounts for detection of toxin in ETEC isolates. 
Specificity and sensitivity ofPCR result can be much more sensitive which is why for 
determination prevalence ofETEC emphasis was given to PCR results. 
As the same sample strains were also subjected to the ELISA test, the ELISA result could 
match with the results of PCR. But we did not find a good correlation between the results 
of PCR and ELISA for the detection of ETEC toxins. We know that PCR is a more 
sensitive method than ELISA. But for detecting toxin expression by PCR, there must be a 
minimum level of DNA concentration in the template that is prepared. In PCR, ST was 
17% whereas 33% found in ELISA and L T was 10% by PCR whereas 17% found in 
ELISA. We therefore did not fmd similar rates ofLT and ST expression by the PCR 
method. Since prior to PCR, DNA concentration in the template was not measured, low 
DNA level might account for this discrepancy. At the same time, ELISA is less sensitive 
but the specific colonies negative for PCR gave a positive result in ELISA. In ELISA 
test, the colonies were subjected to overnight growth with shaking at 37°C, that's why the 
low L T and ST toxin producing strains might have multiplied in larger numbers to 
produce toxins that were detectable by ELISA. For this reason, PCR negative L T and ST 
strains were positive by ELISA. We did not check the broth grown bacteria also by PCR 
and this should be done in future studies. 
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About 13% of PCR positive strains were negative by ELISA. It is possible that either the 
eilB or eslA gene is present as a silent gene or, alternatively, that the levels of expression 
of the gene for these toxin are so low that the toxin are not detected by the ELISA reader. 
The probability of phenotypic silencing may increase even more during storage and re-
cultivation [79]. 
When we established the multiplex-toxin PCR, we particularly aimed to develop a robust 
PCR optimized for use with DNA prepared by the rapid-boil technique to allow 
examination of large strain collections without the need for labor intensive DNA 
preparations and for use in less-well-equipped laboratories, e.g., in developing countries. 
The assay was found to be robust, allowed for accurate identification of the three toxin 
genes with DNA prepared by simple boiling of the bacteria, and allowed rapid 
identification (less than 24 hrs) of ETEC from E. coli strains derived from cultures of 
diarrheal stool samples when the method was tested in the laboratory. It would also be 
possible to extract DNA directly from diarrheal stool samples and test for the presence of 
ETEC by the PCR method. However, this approach would require DNA extraction with a 
commercial kit to avoid PCR inhibitory factors present in the stool. 
These discrepancies of results can be explained by Real time- PCR (RT -PCR). Less copy 
number ofthe toxin genes might justify the loss of toxin expression in ELISA, sometimes 
when the PCR method is used. Thus in future study, rRT-PCR can be carried out to 
evaluate genotypic and phenotypic toxin results specificity. 
The choice of method for any specific laboratory is dependent on equipment, resources, 
and time constraints, but we suggest initial analysis ofETEC colonies from clinical 
isolates by using PCR. Subsequent analyses for CFs could be performed on one to two 
toxin-positive colonies from each original isolate, using either Dot blot or PCR. This 
study shows that both genotypic and phenotypic methods can be used for detection of 
ETEC. The PCR method can be used for large scale analysis of E. coli strains although 
concurrences with phenotypic methods are needed for further verification. 
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Appendix A 
A. Reagents 
1. Bovine serum albumin (BSA) 
Sigma chemical Co., St. Louis, MO, USA 
2. Low binding ELISA microtiter plates Nunc 
Roskilde, Denmark 
3. Ganglioside GMI 
Sigma chemical Co., St. Louis, MO, USA 
4. Goat anti- mouse IgG HRP conjugate 
Jackson Immuno Research, West Grove, P. A., USA 
5. H202 (Hydrogen peroxide) (30%) 
Merck, Darmstadt, Germany 
6. Lincomysin 
Sigma chemical Co., St. Louis, MO, USA 
7. Monoclonal antibodies 
L T 39: 13: I , mouse anti - L TB (lgG I) 
ST 1 :3, mouse anti - ST (lgG I) 
From Ann - Mari Svennerholm, University of Goteborg, Sweden 
8. Ortbopbenylenediamine (OPD) 
Sigma chemical Co., St. Louis, MO, USA 
9. ST - CTB conjugate 
From Ann - Mari Svennerholm, University of Goteborg, Sweden 
10. Tween 20 (polyoxietylensorbitanmonolaurat) 
Sigma chemical Co., St. Louis, MO, USA 
Appendix 
11. Nitrocellulose membrane, 0.45 micron 
Sigma chemical Co., St. Louis, MO, USA 
12. 4 - chloro -1 napthol 
Sigma chemical Co., St. Louis, MO, USA 
13. Methanol (99.9%) 
Riedel-de - Haen 
14. Rabbit anti - mouse immunoglobulin horseradish peroxidase 
Dakopatts 
15. Agarose 
Bio-Rad Laboratory, Richmond, CA, USA 
16. Ethydium Bromide 
Invitrogen, Scotland, UK 
ii 
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Appendix B 
• Preparation of different media: 
1. MacConkey agar plate (1000 mL) 
Peptone 
Lactose 
Nacl 
Bile salts 
Neutral red 
Crystal violet 
Bacto agar 
pH =7.2 
Reagent 
2. Colonization factor antigen (CFA) agar (1000 mL) 
pH =7.4 
Reagent 
Casamino acid 
Yeast extracts 
MgS04 
MnCh 
Bacto agar 
Distilled water 
3. Colonization factor antigen (CFA) brotb (1000 mL) 
Reagent 
Casamino acid 
Yeast extracts 
MgS04 
MnCh 
Bile salts 
Distilled water 
iii 
Amount 
20.0g 
10.0 g 
S.O g 
I.S g 
O.OS g 
1.0 g 
IS.O g 
Amount 
10.0 g 
I.S g 
0.05 g 
O.OOS g 
15 g 
1000mL 
Amount 
10.0 g 
I.S g 
0.05 g 
0.005 g 
I.S g 
1000mL 
Appendix 
4. Colonization factor antigen (CFA) agar with bile (1000 mL) 
pH =7.4 
Reagent 
Casamino acid 
Yeast extracts 
MgS04 
MnCb 
Bacto agar 
Bile salts 
Distilled water 
5. Luria Bertani Broth (LB) 1000 mL 
pH =7.4 
Reagent 
Bacto tryptone 
Nac! 
Bado yeast extracts 
Distilled water 
iv 
Amount 
10.Og 
I.5g 
0.05 g 
0.005 g 
15 g 
1.5 g 
1000mL 
Amount 
10.0 g 
10.0 g 
5.0 g 
1000 mL 
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Appendix C 
I.Reference strains for peR 
Strains 
E. coli ST 641 II 
E. coli 286C2 
E.coli 195 
E. coli VM 75688 
E. coli E34420C 
2.Reference strains for ELISA 
Strains 
E. coli ST 641 I I 
E.coli 286C2 
E. coli VM 75688 
E. coli E34420C 
3. Reference strains for Dot blot assay 
E. coli Strains 
E. coli 258909-3 
E \392-75 
278485-2 
E 11881 /9 
VM 75688 
v 
Toxin type 
STh+ 
Lr 
STp 
Lr, STh+ 
S'l, L'l 
Toxin type 
STh+ 
LT+ 
Lr, STh+ 
S'l, L'l 
CFtype 
CFAlI 
CSI , CS3 
CS2, CS3 
CS4, CS6 
CS5, CS6 
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AppendixD 
D. Solutions 
1. Pbospbate buffer saline (PBS) (lOx) (I Litre) 
pH 7.2-7.4 
Reagent 
KCI (2.68 mM) 
Na2HP04.12 H20 (7.7 mM) 
NaCl (0.l36M) 
KH2P04 (2 mM) 
For PBS- Tween 0.05% Tween 20 was added in IX PBS. 
2. O. 1M Sodium Citrate (1000 mL) 
pH=4.5 
Reagent 
Trinatrium Citrate (Na3C~504.2H20) 
H20 (Deionized) 
Amonut 
2.0 g 
27.5 g 
80.0 g 
2.75 g 
Amount 
29.4g 
IOOOmL 
3. Ortbopbenylene Oiamine (OPO)-Hydrogen peroxide (Substrate) (10 mL) 
Reagent 
OPD 
0.1 M Sodium Cictrate 
30% H20 2 
4. Tris Buffer Saline (TOS) (1000 mL) 
pH=7.5 
Tris (0.02M) 
NaCI (0.5M) 
Reagent 
VI 
Amount 
10.Omg 
10.0 mL 
4.0mL 
Amount 
4.2g 
29.2g 
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5. 4- Chloro-I-Napthol-H202 Substrate (10 mL) 
Reagent 
4- Chloro-l-Naptho, 3 mglml in 
99.9% methano 
Tris Buffer Saline 
30% H20 2 
6. Tris-Borate EDTA buffer (IX) (lLitre) 
Trizma (tris) 
Boric acid 
EDTA Sodium 
Reagent 
7. Loading Dye Composition (6X) (10 ml) 
Reagent 
0.25% BPB (Bromo Phenol Blue) 
0.05% XC (Xyelene Cyanol FF) 
100mM EDTA 
50% Glycerol 
vii 
Amount 
1.7 mL 
8.3 mL 
5.0111 
Amount 
12.lgrn 
6.0 grn 
0.74 gm 
Amount 
0.025 g (Stock I%BPB 2.5 ml) 
0.5 ml (Stock I %XC 0.5 ml) 
2.0 ml (stock 0.5 mM 2.0 ml) 
5.0 ml (stock lOoolo Gly 5.0 ml) 
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Appendix E 
E. Antibodies for toxin ELISA and Dot blot assay: 
• Monoclonal antibodies specific for L T; (MAb L T -39, mouse anti-L T 
IgGI) 
• Monoclonal antibodies specific for ST; (MAb ST-I :3, mouse anti-ST 
IgGI) 
• Monoclonal antibodies specific for CS I ; (MAb CS 1,12:4) 
• Monoclonal antibodies specific for CS2; (MAb CS2, I 0:3) 
• Monoclonal antibodies specific for CS3; (MAb CS3, 10:2a) 
• Monoclonal antibodies specific for CS4; (MAb CS4,4:6) 
• Monoclonal antibodies specific for CS I; (MAb CS5,4:5) 
• Monoclonal antibodies specific for CS6; (MAb CS6, 2A:4) 
• Monoclonal antibodies specific for CS7; (MAb CS7, 5:2) 
• Monoclonal antibodies specific for CSI7; (MAb CSI7, 8:1) 
• Monoclonal antibodies specific for CF All; (MAb CF All, 1:6) 
• Monoclonal antibodies specific for CFAlIll; (MAb CFAlIlI, 3:3) 
• Monoclonal antibodies specific for PCFOI59; (MAb PCFOI59, 5:1) 
• Monoclonal antibodies specific for PCFO 166;(MAb PCFO 166, 1:6) 
• Synthetic ST-CTB conjugate 
VIII 
